av/acrivon-therapeutics--big.svg

COM:ACRIVON

Acrivon

  • Stock

Last Close

6.44

22/11 21:00

Market Cap

221.08M

Beta: -

Volume Today

25.35K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
536K
-
gross profit
-536K
-
selling and marketing expenses
134K
-
general and administrative expenses
1.30M
-
2.47M
89.98%
8.71M
253.12%
21.08M
142.06%
selling general and administrative expenses
1.30M
-
2.47M
89.98%
8.71M
253.12%
21.21M
143.60%
research and development expenses
1.87M
-
13.72M
633.58%
23.95M
74.58%
45.49M
89.94%
other expenses
-2.14M
-
-59K
97.24%
1.49M
2,625.42%
cost and expenses
3.17M
-
16.18M
410.86%
32.66M
101.79%
67.24M
105.89%
operating expenses
3.17M
-
16.18M
410.86%
32.66M
101.79%
66.70M
104.25%
interest expense
-1.49M
-
ebitda
-3.15M
-
-16.15M
411.79%
-32.66M
102.25%
-66.70M
104.25%
operating income
-3.17M
-
-16.18M
410.86%
-32.66M
101.79%
-67.24M
105.89%
depreciation and amortization
13K
-
37K
184.62%
364K
883.78%
536K
47.25%
total other income expenses net
-2.14M
-
-59K
97.24%
1.49M
2,625.42%
6.85M
359.66%
income before tax
-5.31M
-
-16.24M
206.13%
-31.17M
91.88%
-60.39M
93.76%
income tax expense
-1.49M
-
1
100.00%
net income
-5.31M
-
-16.24M
206.13%
-29.68M
82.71%
-60.39M
103.48%
weighted average shs out
12.88M
-
12.91M
0.20%
4.12B
31,828.49%
22.08M
99.46%
weighted average shs out dil
12.88M
-
12.91M
0.20%
4.12B
31,828.49%
22.08M
99.46%
eps
-0.41
-
-1.26
207.32%
-0.01
99.43%
-2.74
37,955.56%
epsdiluted
-0.41
-
-1.26
207.32%
-0.01
99.43%
-2.74
37,955.56%

All numbers in (except ratios and percentages)